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Purpose: Bee venom (BV) is traditionally used in many inflammatory chronic conditions but its 
mechanism of action at molecular level is not fully understood. This study was undertaken to elucidate 
the mechanism of action of bee venom at the molecular level 
Methods: We used lipopolysaccharide (LPS) stimulation in Raw 264.7 macrophage (RM) cells and 
studied the effect of BV on cell proliferation, inflammation related protein expression by western blotting 
and RNA expression by reverse transcriptase polymerase chain reaction (RT-PCR).   
Results: Bee venom was toxic to RM cells above10 µg/ml but reduced the production of nitric oxide 
(NO) at 2–10 µg/ml in LPS stimulated RM cells by inhibiting the expression of inducible nitric oxide 
synthase (iNOS) and cyclooxigenase (COX)-2 via nuclear factor  (NF)-κB. However, bee venom also 
induced the pro-inflammatory cytokine, interleukin (IL)-1β via p38 mitogen activated protein kinase 
(MAPK) which is known to stimulate inflammatory activity.  
Conclusion: It seems that NFκB and p38 MAPK signal pathways are involved in triggering the 
functional activation of LPS-stimulated macrophage. We suggest that some components of bee venom 
can cause inflammation by inducing IL-1β via p38 MAPK while others act as anti-inflammatory by 
suppressing iNOS and COX2 via NFκB.  
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INTRODUCTION 
 
Bee venom (BV) from the sting of Honeybee 
(Apis mellifera) is traditionally used in China 
Korea, Japan for arthritis, tendinitis, bursitis 
and other chronic conditions. It is reported to 
have proinflammatory [1] and anti-
inflammatory effects [2-6]. Several studies 
have reported that following subcutaneous 
injection of a solution of BV into rat paw, as 
an experimentally-produced honeybee’s sting 
effect, the animal showed unique expressions 
of persistent nociception and inflammation [7-
9]. Since the first report of anti-inflammatory 
effect of BV [10], many studies using diverse 
methodologies have supported this finding.  
 
BV contains various peptides, including 
mellitin, apamin, adolapin and enzymes as 
well as non-peptide components such as 
histamine, lipid, carbohydrates [11-13]. 
Excessive production of nitric oxide (NO) and 
prostaglandin (PGE) play an important role in 
various inflammatory diseases [14].  In 
inflammatory reactions, NO is generated from 
arginine, mainly by inducible nitric oxide 
synthase (iNOS) while PGE is generated 
from arachidonic acid mostly by 
cyclooxygenase (COX-2). Recent studies 
have demonstrated that eukaryotic 
transcription factor nuclear factor-kappa B 
(NF-kB) is involved in the regulation of COX-
2 and iNOS expression [15].  Accordingly, 
many substances developed to date to 
prevent inflammatory damage either by 
suppressing the activation of iNOS or COX-2 
directly, or by inhibiting NFκB signalling, 
which regulates them in the transcriptional 
stage [16].  
 
The biological functions of NFκB are involved 
in many pro-inflammatory cytokines such as 
TNF-α, TNF-β, IL-1β, IL-6 and IL-8 [17]. TNF-
α plays a key role in the induction and 
maintenance of inflammation due to 
autoimmune reactions, by activating T cells 
and macrophages and by up-regulating other 
pro-inflammatory cytokines [18].  Likewise, 
IL-1β, one of the most important inflammatory 
cytokines secreted by macrophages, is 
induced by LPS. During inflammation, 
increased release of IL-1β leads to cell or 
tissue damage [19] and thus, reduction in IL-
1β released from macrophages may retard 
inflammatory responses to LPS stimulation. 
Mitogen-activated protein kinase (MAPK) 
pathway, one of the most extensively studied 
intracellular signaling cascades, is also 
seems to have pro-inflammatory responses 
[20,21]  
 
It appears from the reported studies that bee 
venom has both pro-inflammatory and anti-
inflammatory effects; however, the 
mechanisms underlying these events at 
cellular level are not fully understood. 
Therefore, in the present study, we 
investigated the effect of BV on NO 
generation and the expression of iNOS, 
COX-2, NF-κB and P38 MAPK, IL-1β, TNF-α 
in RM cells stimulated by LPS in order to 
identify elements affecting anti-inflammatory 






Bee venom (99.5 % purity) was supplied by 
Chung-Jin Biotech Co. Ltd, Korea. Anti-iNOS, 
COX-2, IL-1β, TNF-α, NFkB, p38MAPK 
antibody and HRP were purchased from 
Santa Cruz Biotechnology Inc, Santa Crutz, 
CA, USA. The primers (see Table 1) were 
synthesised by Bioneer Corporation, Korea. 
Alamar blue was received from Invitrogen, 
USA while RAW 264.7 murine macophages 
were obtained from American Type Culture 




We studied the effect of BV at different doses 
in the LPS stimulated RM cells by measuring 
NO production and the expression of different 
inflammatory enzymes and cytokines at 
protein level by Western blotting and at 
mRNA levels by RT-PCR in order to 
understand the mode of action of bee venom 
on inflammatory pathway.     
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 Preparation of bee venom solution 
 
Dried 0.01 g bee venom was diluted with 10 
ml Dalbeco’s modified eagle’s medium 
(DMEM) medium (10 % foetal bovine serum 
(FBS), 1% penicillin) to make 1000 µg/ml, 
and then filtered. The solution was further 
diluted to 0. 5, 1, 2, 5, and 10 µg/ml before 
actual use. 
  
Culture of Raw 264.7 cells and sample 
treatment 
 
Mouse macrophage cell line Raw 264.7 cells 
were cultured in (DMEM) with 10 % faetal 
bovine serum and 1% penicillin in a 
humidified atmosphere of 5 % CO2 at 37 
o
C. 
The cells were stimulated with LPS 
(1µg/well); 1 h later,  they were treated with 
0, 0.5, 1, 2, 5 and 10 µg/ml of BV and 
cultured for 24 h Various analyses were 
carried out on them as described in the 
following sections. 
 
Cell proliferation assay 
 
To determine the effect of BV on cell 
proliferation, the cells were incubated for 24h 
with BV at different concentrations (0, 0.5,1,2, 
5, 10, 20 µg/ml). Cell proliferation was 
measured by alamar blue (AB) assay. A 
single plate was used for each assay and all 
measurements were conducted on a 
microplate reader (UVmax, Molecular 
Devices). In the assay, 10 µl AB reagent 
(Serotec) was added to each well, and after 3 
h of incubation at 37 
0
C under 5 % CO2 in a 
humidified atmosphere, the absorbance 
difference was determined at 570nm using a 
spectrophotometer (Tecan Sunrise™ 
Absorbance Reader). The cell proliferation 
was calculated by comparing with control and 
expressed in percent. 
 
Nitric oxide assay 
 
To examine the effects of BV on NO 
production, we measured the levels of nitrite 
(an index of NO formation) produced by LPS. 
Thereafter, NO production assay was used to 
confirm the results. The RAW 264.7 cells 
were transferred to a 96-well plate (1000 
cells/well) and incubated overnight. The cells 
were stimulated with LPS (1µg/well), and 1 h 
later, they were treated with 0, 0.5,1, 2, 5 and 
10 µg/ml of BV and cultured for 24 h. One 
hundred microlitres of the culture 
supernatants were transferred into another 
96-well plate and treated with 100 µl of 
Greiss reagent solution. After waiting for 
reaction to take place at room temperature, 
light absorption was measured at 570 nm 
with a spectrophotometer (Tecan Sunrise™ 
Absorbance Reader). NO was assessed with 
the aid of a standard curve prepared with 
standard sodium nitrite solutions (0, 3.75, 7.5, 




Cellular proteins were extracted from 
untreated and treated cells in cold lysis buffer 
(50 nM Hepes at pH 7.0, 250 nM NaCl and 5 
nM EDTA), and the protein concentration of 
the samples were determined by Bio-protein 
assay in 96 wells. This solution was diluted 
with water to 1:4; proteins in the cell samples 
were also diluted with cold PBS to 1:4. After 
loading 10 µl of diluted protein samples into 
the wells and waiting for 10 min, the 
developed colour was measured in all 96 
wells at 600 nm in a spectrophotometer 
(Tecan Sunrise™ Absorbance Reader). 
Protein content was computed with the aid of 
a standard curve prepared using bovine 
serum albumin (BSA) as a standard in a 
concentration range of 0.02 – 1.34 µg/ml. 
  
Western blot analysis 
 
After protein concentration was determined, 
40 µg samples from treated and untreated 
cells extracts were separated on a 10 % 
sodium dodesyl sulfate (SDS)-polyacrylamide 
gel electrophoresis. The protein bands were 
transferred to a nitrocellulose membrane 
electrophoretically at 4 
0
C at 100 V for 1 h. 
The membrane was blocked with 5 % 
skimmed milk, washed 3 times with Tween 
20-Tris-buffered saline (TBS-T), and transfer 
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of bands was confirmed by Ponceus solution 
at room temperature.  The first antibody 
against iNOS, COX-2, NFkB, TNFα, IL1β, 
P38 MAPK and β-actin was added and 
incubated for 2 h. After washing with TBS-T 3 
times (each time for 15 min), the membrane 
was incubated with a 1:1000 dilution of 
horseradish peroxidase-conjugated second-
dary antibody for 1 h at room temperature. 
The membrane was again washed 3 times 
with TBS-T and then developed by enhanced 
chemi-luminescence (Amersham Life 
Science, Arlingon Heights, IL, U.S.A) on an x-
ray film. 
 




 cells/ml) were taken in 
culture disks and pretreated with bee venom 
at 0, 0.5, 1, 2, 5, 10 µg/ml and after one 1 h, 
the cells were treated with LPS (1 µg/ml). 
After 24 h, the cells were harvested into a 1.5 
ml Eppendorf tube using 1 ml of Trizol 
reagent. The samples were homogenised 
and incubated for 5 min at room temperature 
to permit the complete dissociation of 
nucleoprotein complexes. Then, 0.2 ml of 
chloroform was added and the tubes were 
shaken vigorously (manually) for 15 sec and 
incubated for 2 to 3 min. The samples were 
centrifuged at 13000 rpm for 15 min at 4 °C, 
and separated into a lower red, phenol-
chloroform phase, an interphase, and a 
colourless upper aqueous phase. The 
aqueous phase was transferred to a fresh 
tube and RNA was precipitated from the 
aqueous phase by mixing with 0.5 ml 
isopropyl alcohol. Subsequently, 0.5 ml of 
isopropyl alcohol was added and the samples 
were incubated at room temperature for 10 
min and centrifuged at 13000 rpm for 10 min 
at 4°C. The supernatant was removed, the 
RNA pellet was washed once with 75 % 
ethanol (1 ml), and centrifuged at 7500 rpm 
for 5 min at 4°C. At the end of the procedure, 
the RNA pellet was briefly dried at room 
temperature for 5 min, 20 ul of RNase-free 
water was added to it, and then incubated for 
10 min at 56°C. Finally, the concentration of 
the RNA was measured with a spectro-
photometer while its quality was assessed by 
agarose gel electrophoresis.  
 
Reverse transcriptase polymerase chain 
reaction (RT-PCR)  
 
cDNA was synthesized from RNA isolated 
from cells using a SuperScript
TM
 II kit 
(Invitrogen, USA). Cycle parameters were 
initial denaturation for 2 min at 95 
0
C, 
annealing for 1min at 57, 60, 60, 55, 60 and 
54 
0
C for NFκB, COX-2, iNOS, TNFα, IL-1β 
and GAPDH, respectively, elongation for 1 
min at 72 
0
C and final extension for 10 min at 
72 
0
C. Primer sequence (Table 1) of the 
NFκB, COX-2, iNOS, TNFα, IL-1β and 
GAPDH (for standardization) were amplified 
out of each cDNA batch with 35, 30, 30, 30, 
30 and 30 amplification cycle, respectively. 
The resulting PCR products were separated 
in 2 % agarose gel and visualised by 




The data are presented as mean ± SEM. All 
data were analysed by one-way ANOVA  and 
differences between the means were 
assessed with Duncan’s multiple range tests 
(DMRT). Differences were considered 
significant at P < 0.05. All analyses were 
carried out using SPSS Software ver.11.5 




Effect of bee venom on cell proliferation 
 
The results indicate that BV-treated cells 
increased proliferation up to a dose of 0.5 – 
2.0 µg/ml. However, BV did not show any 
toxic effect at 5 - 20 µg/ml and the number of 
cells decreased more than untreated control. 
 
Effect of BV on NO production and iNOS 
expression 
 
The results (see Fig 1) indicate that NO 
production reduced significantly (p < 0.05) in 
a dose-dependent manner with BV treatment.
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Figure 1: The effects of bee venom on NO 
production and iNOS protein expression in LPS 
stimulated Raw 264.7 cells. Note: Values 
represent means ± SEM of seven samples. Means 
with different superscripts (a, b, c) are significantly 
different (p < 0.05). 
 
Also, bee venom consistently inhibited the 
expression of iNOS protein in RAW 264.7 
cells in a concentration dependent manner. 
These results demonstrated that bee venom 
produced a concentration-dependent 
inhibition of NO production and iNOS protein 
expression in response to LPS. 
 
Effect of BV on COX-2 expression 
 
The results, shown in Fig 2, indicate that bee 
venom at low concentrations (0.5 – 2.0 
µg/ml) had no significant effect (p < 0.05) on 
COX-2 expression, but at higher 
concentrations (5 - 10 µg/ml), bee venom 
significantly reduced COX-2 expression in the 
LPS-stimulated RM cells. Thus, bee venom 
inhibited COX-2 activity and protein 
expression in RAW 264.7 cells stimulated 
with LPS. 
 
Effect of BV on P38-MAPK and IL-1β 
expressions 
 
The results in Fig 3 showed that bee venom 
exerted a dose-dependent increase in the 
expression of both p38 MAPK and IL-1β. The 
trend was similar and the rise in expressions 
were significant (p<0.05) at doses of 5 - 10 
µg/ml bee venom. Thus, these data 
established a pro-inflammatory effect of BV 
via p38 MAPK pathway. 
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Figure 2: The effect of bee venom on COX-2 
protein expression in RAW 264.7 cells. Note: 
Values represent the means ± SEM of seven 
samples. Means with different superscripts (a, b, 




Figure 3: Effect of bee venom on P38-MAPK and 
IL1β expressions in LPS-stimulated RAW 264.7 
cells. Note: Values represent the means ± SEM of 
seven samples. Means with the different 
superscripts (a, b, c) are significantly (p<0.05) 
different.  
 
Effect of BV on NFκB activation and 
mRNA cytokine expression  
 
The results in Fig 4 and Table 2 show 
significant decreases in the expressions of 
iNOS, COX-2 and NFkB at concentrations of 
2 - 10 µg/ml of bee venom in LPS-stimulated 
RAW cells. BV treatment also induced 
increased expression of IL-1β at lower 
concentration but the expression was 
significantly greater (p < 0.05) at higher BV 
concentrations (5-10 µg/ml). However, the 
effect on the expression of TNFα was not 
significant although expression appeared to 




Figure 4: Effect of bee venom on NFκB activation 
and mRNA cytokine expression in LPS-stimulated 




In this paper, we have presented data to 
show that bee venom controlled NO 
production in activated macrophages via the 
inhibition of iNOS expression, and also 
suppressed the expression of COX-2 acting 
at a transcriptional level. It is also evident 
from the results that bee venom inhibited 
LPS-induced expression of iNOS and COX2 
genes through the blocking of NFκB 
activation at mRNA and protein expression 
levels. Recently, it was reported that bee 
venom exhibits anti-arthritic effect by 
reducing the expression of  iNOS and COX-2 
through suppression of NFkB [3,15]. 
 
In this study, we observed increased activity 
of p38 MAPK which enhanced IL-1β 
expression in RM cells. This suggests that 
p38 MAPK is a critical mediator for the 
release of pro-inflammatory cytokines such 
as IL-1β in RM cells due to treatment with 
bee venom (BV). 
 
Although BV has anti-inflammatory proper-
ties, however, it can also induce inflammation 
since the p38MAPK activated by several 
different stimuli positively regulates a variety 
of genes  involved  in  inflammation,  such as 
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Table 2: Effect of bee venom (BV) on relative mRNA expression (mean ± SD) of iNOS, IL-1β, COX-2, TNF-
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   a, b, c:  means with different superscripts are significantly different (p<0.05). 
 
TNF-α and IL-1β [20,22]. These cytokines 
appear to be interlinked in a cascade, being 
produced serially by cells during an 
inflammatory response. Cumulative evidence 
indicates that an abnormality in the 
production or functions of TNFα and IL-1β 
play a role in many inflammatory lesions [23]. 
Bee venom induced an increase in the 
activity of p38MAPK which activated IL-1β 
expression at protein and mRNA levels 
 
iNOS, TNFα, COX2 and IL-1β. Therefore, 
inhibitors of NFκB activation are important in 
anti-inflammatory activity. Our data show that 
bee venom can directly inhibit NFκB 
activation and suppress the expression of 
iNOS and COX2. Although bee venom 
inhibited NFκB activation, it also increased 
the activation of TNFα and IL-1β mRNA 
expression. The naturally occurring peptides 
of whole bee venom have various 
pharmacological potencies to produce local 
inflammation, nociception and pain 
hypersensitivity in mammals. Over 50 % of 
whole bee venom plays a central role in the 
production of local inflammation [24]; 
however, these components exhibit anti-




NFκB and p38 MAPK signal pathways are 
involved in triggering the functional activation 
of LPS-stimulated macrophage and play an 
important role in the release of pro-
inflammatory and anti-inflammatory 
cytokines. We suggest that some 
components of bee venom can induce 
inflammation by inducing IL-1β via p38 MAPK 
but some other components act as anti-
inflammatory by suppressing iNOS and 
COX2 via NFκB when there is already 
inflammation. Further study is required to 
confirm the activity of individual components 
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